1 completed, 1 recruiting, 1 withdrawn. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Recruiting 1, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow Foodborne Diseases: new trials by email Literature Review of Foodborne Diseases trials Research Report on Foodborne Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis Botulinum toxin, Standard-of-care corticosteroid injections - Carpometacarpal Sprain, Thumb Sprain | Phase 3 | Recruiting | Rhode Island Hospital | 50 | 2023-08-27 | 2024-11-20 |
| Phase 3, Randomized, Safety, Lot Consistency and Clinical Benefit Study of Recombinant Botulinum Vaccine A/B rBV A/B, Placebo (USP sterile saline for injection) - Botulism | Phase 3 | Withdrawn | DynPort Vaccine Company LLC, A GDIT Company | 2017-10-01 | 2018-12-04 | |
| Pilot Study on the Usefulness of 3,4-diaminopyridine in the Treatment of Botulism 3,4-diaminopyridine - Botulism | Phase 2 / Phase 3 | Completed | Centre Hospitalier Universitaire, Amiens | 3 | 2011-09-01 | 2025-09-19 |
Botulism (3)
Bacterial Infections (3) · Bacterial Infections and Mycoses (3) · Chemically-Induced Disorders (3) · Clostridium Infections (3) · Gram-Positive Bacterial Infections (3) · Infections (3) · Nervous System Diseases (3) · Neuromuscular Diseases (3) · Neuromuscular Junction Diseases (3) · Neurotoxicity Syndromes (3) · Poisoning (3)
Amifampridine (1) · Botulinum Toxins (1) · Botulinum Toxins, Type A (1) · Injections (1)
Centre Hospitalier Universitaire, Amiens (1) · DynPort Vaccine Company LLC, A GDIT Company (1) · Rhode Island Hospital (1)
France (1) · United States (1)
George A Saviolakis, M.D., Ph.D. (1)